Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Moraxella catarrhalis surface proteins (McSPs), particularly Ubiquitous Surface Proteins (UspAs) such as UspA1 and UspA2, are crucial for bacterial pathogenicity. They mediate adhesion to host cells, confer serum resistance by binding complement regulatory molecules like C4BP and C3/C3b, and facilitate iron acquisition. Their sequence diversity contributes to immune evasion and poses challenges for therapeutic targeting. Other proteins, like CopB, contribute to iron uptake. McSPs are considered therapeutic targets for preventing or treating M. catarrhalis infections.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Moraxella catarrhalis Surface Proteins (McSPs).